Business Context and Reporting Period
Company: Superior Group of Companies, Inc. (SGC)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: The Company operates three segments: Branded Products (customized merchandising and uniforms), Healthcare Apparel (scrubs and protective apparel), and Contact Centers (outsourced business process services). The Company is an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $131,736 | $129,162 | $270,578 | $259,935 |
| Gross Margin | $50,755 (38.5%) | $47,596 (36.8%) | $106,072 (39.2%) | $94,704 (36.4%) |
| Net Income | $600 | $1,213 | $4,512 | $2,101 |
| Diluted EPS | $0.04 | $0.08 | $0.27 | $0.13 |
| EBITDA (Non-GAAP) | $5,559 | $7,428 | $15,190 | $14,331 |
| Cash from Operations (YTD) | $16,300 | $38,095 | ||
| Cash & Equivalents (End of Period) | ||||
| Total Debt (Outstanding) | $78,500 | $94,375 | ||
| Working Capital | $169,321 | $178,771 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.0% in Q2 and 4.1% YTD compared to the prior year. Growth was driven by the Branded Products (+2.1% Q2, +4.3% YTD) and Contact Centers (+9.1% Q2, +8.0% YTD) segments, partially offset by a decline in Healthcare Apparel (-5.3% Q2, -0.7% YTD) due to lower volume from store-based wholesale customers.
- Profitability: Q2 Net Income decreased 50.5% to $0.6 million, primarily due to a 11.5% increase in selling and administrative (S&A) expenses. However, YTD Net Income increased 114.8% to $4.5 million, driven by higher gross margins and a significant reduction in interest expense.
- Interest Expense: Interest expense declined 41.3% in Q2 and 35.9% YTD due to a reduction in weighted average outstanding borrowings and a lower weighted average interest rate (6.5% in Q2 2024 vs. 7.2% in Q2 2023).
- Operating Expenses: Consolidated S&A expenses increased 11.5% in Q2 and 11.9% YTD. Increases were attributed to higher employee-related costs, marketing expenditures, and fair value adjustments on acquisition-related contingent liabilities and written put options.
- Liquidity: Cash and cash equivalents decreased to $13.4 million from $19.9 million at year-end 2023, primarily due to debt repayments totaling $25.9 million in the first half of 2024.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management anticipates spending more on capital expenditures in 2024 than in 2023. The Company expects to continue paying dividends as financial conditions permit. No specific numerical guidance for full-year revenue or earnings was provided in this filing.
- Unusual Items:
- Written Put Options: Remaining unexpired options totaling 132,924 shares expired in the first half of 2024, resulting in a $2.4 million reduction in liabilities. The Company recognized unrealized losses of $0.7 million on these options YTD 2024.
- Contingent Liabilities: The Company settled a $0.5 million obligation related to the Sutter's Mill acquisition in Q1 2024. An estimated $1.7 million liability remains for the Guardian Products acquisition, with $1.0 million expected to be paid in Q3 2024.
- Risks and Contingencies:
- Internal Controls: A material weakness in internal control over financial reporting persists as of June 30, 2024, relating to segregation of duties and change management in the Contact Centers segment's IT systems. Remediation efforts are ongoing.
- Geopolitical Risk: Manufacturing facilities in Haiti are at risk of disruption due to civil unrest, which could impact the Healthcare Apparel segment's supply chain.
- Market Risk: The Company is exposed to interest rate risk on variable-rate debt (SOFR-based) and foreign currency exchange risk, though less than 5% of sales are denominated in foreign currencies.
Investor Verification Checklist
- Internal Control Remediation: Verify the timeline and progress of remediation for the material weakness in the Contact Centers segment's IT systems.
- Haiti Operations: Assess the current status of civil unrest in Haiti and its potential impact on the Healthcare Apparel segment's production capacity.
- Debt Covenants: Confirm continued compliance with the Credit Agreement's fixed charge coverage ratio (1.25:1) and net leverage ratio (4.0:1).
- Contingent Consideration: Monitor the final settlement amounts for the Guardian Products acquisition, as actual payments may differ from the current $1.7 million estimate.
- Share Repurchases: Note that no shares were repurchased in Q2 2024; 657,451 shares remain available under the existing program.